# AMPICILLIN

NDC: 51662-1595
Generic name: AMPICILLIN
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20220818

FDA application: ANDA062719

## Active ingredients

- AMPICILLIN SODIUM: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1595"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1595
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e47a21b1-bbdb-4321-e053-2a95a90a3b4a